E3112

DRUG2 trials

Sponsors

EA Pharma Co., Ltd.

Conditions

Healthy Male ParticipantsHealthy Male Volunteers

Early Phase 1

A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects

CompletedNCT03014895

EA Pharma Co., Ltd.Healthy Male Volunteers

Start: 2017-01-25End: 2017-11-22Updated: 2018-11-14

Phase 1

A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants

CompletedNCT03922633

EA Pharma Co., Ltd.Healthy Male Participants

Start: 2019-04-22End: 2020-10-01Updated: 2021-03-15